國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

全民健保藥事制度之法律分析 = The Legal Analysis o...

吳維仁

全民健保藥事制度之法律分析 = The Legal Analysis of the Pharmaceutical Jurisprudence within National Health Insurance

紀錄類型:	書目-語言資料,印刷品 : 單行本
並列題名:	The Legal Analysis of the Pharmaceutical Jurisprudence within National Health Insurance
作者:	吳維仁,
其他團體作者:	國立高雄大學
出版地:	[高雄市]
出版者:	撰者;
出版年:	2013[民102]
面頁冊數:	159面圖，表格 : 30公分;
標題:	全民健保
標題:	National Health Insurance
電子資源:	http://handle.ncl.edu.tw/11296/ndltd/99698673275152319608
附註:	參考書目：面145-151
附註:	102年10月31日公開
摘要註:	我國全民健保自1995年開辦以來，其中健保藥費之支出乃逐年成長，且全民健保藥物給付項目及支付標準（即所謂「藥價基準」）除攸關保險對象之就醫權益外，亦涉及保險醫事服務機構及藥品供應商之營業利益。本研究除就藥價黑洞（或稱藥價差）之議題加以探討之外，並針對我國全民健保藥事制度之相關法律及法規命令加以分析，自保險人、保險對象、保險醫事服務機構及藥品供應商等當事人之不同面向，研究全民健保藥事制度之相關法規範（包括藥品給付項目、事前審查、支付標準及藥價調查制度），試行對我國全民健保規範之藥事制度所干涉之基本權作違憲審查，最後就現行全民健保法尚有何缺失之處，提出建議修法方向。 Ever since National Health Insurance (NHI) has been put in operation in 1995, of which, the NHI medicine expenditure has been gradually rising year after year, and the benefit items and payment standard (i.e. the drug list and payment scheme) of the NHI medicine not only affect the right to receive medical care for the insured, but also get involved in the business interests of the insurance medical service organizations and medicine suppliers. The goal of this study is to investigate the issues of the drug price black hole (or medicine price difference), also, to analyze the related laws and regulation orders of the Pharmaceutical Jurisprudence within NHI. This study will start from the different aspects of the insurer, the insured, the insurance medical service organizations and drug suppliers to study the related legal regulations (including the drug payment items, prior review, payment standard, and drug price survey system) of the NHI system to attempt to proceed with unconstitutional inspection for the pharmaceutical jurisprudence of NHI involved in basic rights for medical care, finally, to give comment on the amendment of law at any fault of the National Health Insurance Law.

全民健保藥事制度之法律分析 = The Legal Analysis of the Pharmaceutical Jurisprudence within National Health Insurance
吳, 維仁

全民健保藥事制度之法律分析 = The Legal Analysis of the Pharmaceutical Jurisprudence within National Health Insurance / 吳維仁撰 - [高雄市] : 撰者, 2013[民102]. - 159面 ; 圖，表格 ; 30公分.
參考書目：面145-151102年10月31日公開.
全民健保National Health Insurance

全民健保藥事制度之法律分析 = The Legal Analysis of the Pharmaceutical Jurisprudence within National Health Insurance
LDR:03345nam0a2200289 450 001 389561
005 20170214092620.0
009 389561
010 0 $b 精裝
010 0 $b 平裝
100 $a 20170214d2013 k y0chiy05 e
101 1 $a chi $d chi $d eng
102 $a tw
105 $a ak am 000yy
200 1 $a 全民健保藥事制度之法律分析 $d The Legal Analysis of the Pharmaceutical Jurisprudence within National Health Insurance $z eng $f 吳維仁撰
210 $a [高雄市] $c 撰者 $d 2013[民102]
215 0 $a 159面 $c 圖，表格 $d 30公分
300 $a 參考書目：面145-151
300 $a 102年10月31日公開
314 $a 指導教授：張永明
328 $a 碩士論文--國立高雄大學法律學系碩士班
330 $a 我國全民健保自1995年開辦以來，其中健保藥費之支出乃逐年成長，且全民健保藥物給付項目及支付標準（即所謂「藥價基準」）除攸關保險對象之就醫權益外，亦涉及保險醫事服務機構及藥品供應商之營業利益。本研究除就藥價黑洞（或稱藥價差）之議題加以探討之外，並針對我國全民健保藥事制度之相關法律及法規命令加以分析，自保險人、保險對象、保險醫事服務機構及藥品供應商等當事人之不同面向，研究全民健保藥事制度之相關法規範（包括藥品給付項目、事前審查、支付標準及藥價調查制度），試行對我國全民健保規範之藥事制度所干涉之基本權作違憲審查，最後就現行全民健保法尚有何缺失之處，提出建議修法方向。 Ever since National Health Insurance (NHI) has been put in operation in 1995, of which, the NHI medicine expenditure has been gradually rising year after year, and the benefit items and payment standard (i.e. the drug list and payment scheme) of the NHI medicine not only affect the right to receive medical care for the insured, but also get involved in the business interests of the insurance medical service organizations and medicine suppliers. The goal of this study is to investigate the issues of the drug price black hole (or medicine price difference), also, to analyze the related laws and regulation orders of the Pharmaceutical Jurisprudence within NHI. This study will start from the different aspects of the insurer, the insured, the insurance medical service organizations and drug suppliers to study the related legal regulations (including the drug payment items, prior review, payment standard, and drug price survey system) of the NHI system to attempt to proceed with unconstitutional inspection for the pharmaceutical jurisprudence of NHI involved in basic rights for medical care, finally, to give comment on the amendment of law at any fault of the National Health Insurance Law.
510 1 $a The Legal Analysis of the Pharmaceutical Jurisprudence within National Health Insurance $z eng
610 0 $a 全民健保 $a 藥事制度 $a 藥價基準 $a 藥價黑洞 $a 藥價差 $a 事前審查 $a 藥價調查
610 1 $a National Health Insurance $a pharmaceutical jurisprudence $a drug list and payment scheme $a drug price black hole $a drug price difference $a prior review $a drug price survey
681 $a 008M/0019 $b 380101 2622 $v 2007年版
700 1 $a 吳 $b 維仁 $4 撰 $3 614435
712 0 2 $a 國立高雄大學 $b 法律學系碩士班 $3 166036
801 0 $a tw $b NUK $c 20131004 $g CCR
856 7 $z 電子資源 $2 http $u http://handle.ncl.edu.tw/11296/ndltd/99698673275152319608